EMA seeks executive director
Andreas Pott will be acting executive director until position is filled
While EMA searches for a permanent replacement, its current head of administration, Andreas Pott, will serve as acting executive director.
University of Hamburg graduate, Pott has been the agency’s administration chief since 2000, having previously worked for the European Parliament and the EU’s translation service.
Swede Lönngren is a former deputy director-general of the Swedish Medical Products Agency (MPA).
You may also like
Pharma 5.0
![FPT launches MediSight AI framework to accelerate pharma digital transformation and regulatory compliance]()
FPT launches MediSight AI framework to accelerate pharma digital transformation and regulatory compliance
The new AI-powered platform combines autonomous digital workers, interoperable healthcare data and compliance tools to help pharmaceutical manufacturers, medical device companies and healthcare providers scale AI adoption
Regulatory
![Early phase analytical strategy for biosimilars in a shifting regulatory landscape]()
Early phase analytical strategy for biosimilars in a shifting regulatory landscape
As FDA and EMA guidance continues to reinforce analytical comparability as the foundation of biosimilar development, investing in comprehensive early-stage characterisation is becoming essential to reduce uncertainty and improve development outcomes, says Dr Andrew J. Reason, CEO at BioPharmaSpec
Hi Tech Manufacturing
![Gerresheimer significantly accelerates mould development in medical technology with “Digital Mold”]()
Gerresheimer significantly accelerates mould development in medical technology with “Digital Mold”
Linking the digital twin of the mould with production data. Virtual mould and process optimisation prior to physical construction
Mould Lifecycle Management as the foundation for data analytics and AI applications in mould development and production
